Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl

被引:0
|
作者
Kaduk, James A. [1 ,2 ]
Dosen, Anja [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
基金
加拿大创新基金会; 加拿大自然科学与工程研究理事会;
关键词
benserazide; Serazide; crystal structure; Rietveld refinement; density functional theory; DENSITY;
D O I
10.1017/S0885715624000496
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of benserazide hydrochloride Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Benserazide hydrochloride Form I crystallizes in space group P2(1)/n (#14) with a = 19.22983(15), b = 14.45066(10), c = 4.57982(2) & Aring;, beta = 93.6935(3), V = 1270.014(15) & Aring;(3), and Z = 4 at 295 K. The crystal structure contains pairs of hydrogen-bonded benserazide cations, which are hydrogen bonded to chloride anions, resulting in chains along the c-axis. In addition, O-H & ctdot;Cl, N-H & ctdot;O, O-H & ctdot;N, and O-H & ctdot;O hydrogen bonds link the cations and anions into a three-dimensional framework. The powder pattern has been submitted to ICDD (R) for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页数:7
相关论文
共 50 条
  • [1] STRUCTURE OF 3-METHYLCYTIDINIUM CHLORIDE, C10H16N3O5+.CL-
    JASKOLSKI, M
    ALEJSKA, M
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1985, 41 (APR) : 599 - 602
  • [2] Crystal structure of alfuzosin hydrochloride, C19H28N5O4Cl
    Kaduk, James A.
    POWDER DIFFRACTION, 2022, 37 (03) : 171 - 182
  • [3] Crystal structure of minocycline hydrochloride dihydrate form A, C23H28N3O7Cl (H2O)2
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (01) : 59 - 65
  • [4] CRYSTAL-STRUCTURE OF 3,4-DIMETHOXY-PHENETHYLAMINE (DMPEA) HYDROCHLORIDE DIHYDRATE (C10H16O2N+CL-,2H2O)
    PATTANAYEK, RR
    DATTAGUPTA, JK
    SAHA, NN
    ACTA CRYSTALLOGRAPHICA SECTION A, 1984, 40 : C86 - C86
  • [5] Crystal structure of alectinib hydrochloride Type I, C30H35N4O2Cl
    Kaduk, James A.
    Rost, Megan M.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (03) : 170 - 175
  • [6] The salt crystal structure of etoricoxib hydrochloride, C18H16Cl2N2O2S
    Ma, Yu-Heng
    Hong, Wei-Pu
    Qian, Yan-Ling
    Tao, Zhen-Wei
    Hou, Shi-Qi
    Guo, Jia-Le
    Ma, Wen-Jing
    Wang, Yi-Hong
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2025, 240 (01): : 23 - 24
  • [7] Crystal structure of tramadol hydrochloride, C16H26NO2Cl
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (03) : 242 - 249
  • [8] Crystal structure of 2,6-dimethylpyridinium hydrochloride, (C7H10N)Cl
    Nuss, H
    Nuss, J
    Jansen, M
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2005, 220 (01): : 95 - 96
  • [9] Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 43 - 52